Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Immunomodulatory Properties of Ketamine in Sepsis

This study is ongoing, but not recruiting participants.
Sponsor:
Information provided by:
Beth Israel Deaconess Medical Center
ClinicalTrials.gov Identifier:
NCT01089361
First received: March 12, 2010
Last updated: October 19, 2010
Last verified: October 2010
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is ongoing, but not recruiting participants.
  Estimated Study Completion Date: June 2011
  Primary Completion Date: June 2010 (Final data collection date for primary outcome measure)